{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-095801","form_type":"8-K","ticker":"CVSI","cik":"0001510964","company_name":"CV Sciences, Inc.","filed_at":"2024-08-13T23:59:59+00:00","discovered_at":"2026-05-14T18:03:13.314070+00:00","generated_at":"2026-05-31T09:41:12.039303+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"CV Sciences Q2 2024 revenue flat at $4.0M; gross margin improves to 47%, adjusted EBITDA near breakeven","bullets":["Revenue $4.0M flat YoY and sequentially; B2C sales up 4% offset by B2B decline of 3%.","Gross margin 47.0% vs 43.3% YoY, best in 13 quarters; operating loss narrowed to $0.6M from $1.1M.","Adjusted EBITDA loss just $6,000, near cash-flow breakeven; cash balance $0.5M vs $1.3M year-end 2023.","Closed acquisition of Elevated Softgels in May 2024; appointed Maxim Group as financial advisor for strategic options.","Received net proceeds of $0.9M from Streeterville financing; remains top hemp extract brand per SPINS."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-095801","json":"https://secwatch.observer/filing/0000950170-24-095801.json","markdown":"https://secwatch.observer/filing/0000950170-24-095801.md","text":"https://secwatch.observer/filing/0000950170-24-095801.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1510964/000095017024095801/0000950170-24-095801-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1510964/000095017024095801/cvsi-20240813.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T09:41:12.039303+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}